These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9116218)

  • 1. L-carnitine treatment improves brain stem auditory evoked potentials in diabetic rats.
    Yildiz O; Ozata M; Ozkardeş A; Corakçi A; Gündoğan N; Gündoğan MA
    Neuroreport; 1996 Nov; 7(18):2957-9. PubMed ID: 9116218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
    Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of aminoguanidine and L-carnitine treatments on somatosensorial evoked potentials in alloxan-diabetic rats.
    Yildiz O; Ozata M; Ozkardeş A; Deniz G; Yildirimkaya M; Corakçi A; Yardim M; Gündoğan MA
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):526-31. PubMed ID: 8897458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the Chinese Yi-Qi-Bu-Shen Recipe extract on brainstem auditory evoked potential in rats with diabetes.
    Liu DS; Gao W; Lin WW; Hao YY; Zhong LH; Li W; Inoguchi T; Takayanagi R
    J Ethnopharmacol; 2011 Sep; 137(1):414-20. PubMed ID: 21669272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ; ter Laak MP; Kamal A; Gispen WH
    Brain Res; 2005 Feb; 1035(1):86-93. PubMed ID: 15713280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta.
    Irat AM; Aktan F; Ozansoy G
    J Pharm Pharmacol; 2003 Oct; 55(10):1389-95. PubMed ID: 14607021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged brainstem auditory evoked potential latencies in tropical pancreatic diabetics with normal hearing.
    Alexander M; Thomas SV; Mohan PK; Narendranathan M
    Electromyogr Clin Neurophysiol; 1995 Mar; 35(2):95-8. PubMed ID: 7781579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of L-carnitine on presbyacusis in the rat model.
    Derin A; Agirdir B; Derin N; Dinç O; Güney K; Ozcaglar H; Kilinçarslan S
    Clin Otolaryngol Allied Sci; 2004 Jun; 29(3):238-41. PubMed ID: 15142068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG; Kumar A; Sharma SS
    Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronological changes in compromised olivocochlear activity and the effect of insulin in diabetic Wistar rats.
    Wu HP; Guo YL; Cheng TJ; Hsu CJ
    Hear Res; 2010 Dec; 270(1-2):173-8. PubMed ID: 20678565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of central neuropathy in type II diabetes mellitus by multimodal evoked potentials.
    Dolu H; Ulas UH; Bolu E; Ozkardes A; Odabasi Z; Ozata M; Vural O
    Acta Neurol Belg; 2003 Dec; 103(4):206-11. PubMed ID: 15008505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of auditory brainstem function in diabetic patients.
    Tóth F; Várkonyi TT; Rovó L; Lengyel C; Légrády P; Jóri J; Czigner J; Kiss JG
    Int Tinnitus J; 2003; 9(2):84-6. PubMed ID: 15106279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
    Marzo A; Corsico N; Cardace G; Morabito E
    Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
    Di Giulio AM; Lesma E; Gorio A
    J Neurosci Res; 1995 Feb; 40(3):414-9. PubMed ID: 7538169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline response in alloxan-induced diabetic rats.
    Satar B; Yildiz O; Karatas E; Boydag S; Akkaya A
    Acta Otolaryngol; 2008 Nov; 128(11):1221-6. PubMed ID: 19241606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of auditory brainstem function in elderly diabetic patients with presbycusis.
    Kovacií J; Lajtman Z; Ozegović I; Knezević P; Carić T; Vlasić A
    Int Tinnitus J; 2009; 15(1):79-82. PubMed ID: 19842349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-carnitine treatment partially restores urinary bladder function of streptozotocin diabetic rats.
    Gur S; Irat AM
    Urol Int; 2008; 81(3):340-6. PubMed ID: 18931555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of the brainstem auditory evoked potential in the early diagnosis of cranial nerve neuropathy associated with diabetes mellitus.
    Al-Azzawi LM; Mirza KB
    Electromyogr Clin Neurophysiol; 2004; 44(7):387-94. PubMed ID: 15559072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment.
    Biessels GJ; Cristino NA; Rutten GJ; Hamers FP; Erkelens DW; Gispen WH
    Brain; 1999 Apr; 122 ( Pt 4)():757-68. PubMed ID: 10219786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
    Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
    Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.